A prospective, comparative evaluation of an augmented reality tool (Postural Video™) vs. standard SGRT for efficient patient setup
Abstract
Background: Surface guided radiation therapy (SGRT) for patient positioning and motion management during radiation therapy is used on ~40% of US linear accelerators. Postural Video™ (PV), an augmented reality tool for SGRT, is showing a live patient video feed against an outline of the intended treatment position, at patient setup and intrafraction monitoring. A study was performed to assess any potential additional values of SGRT with PV, versus SGRT alone.
Materials and methods: Two radiation therapy centers, comparable across patient numbers, case mix, treatment times and staff experience, were selected to compare performance difference in SGRT with/without PV, focused on productivity. Site A used SGRT alone for patient setup, while Site B used SGRT with PV. Both sites were proficient in the use of SGRT prior to the study. 250 treatment delivery fractions per site were analyzed, evaluating average patient setup time, average wait time and frequency of repeated radiographic imaging. A qualitative survey completed information of PV impact on setup quality, access, and efficiency.
Results: Average time saving per patient by introducing PV is 28.8% plus additional 60 sec time saving in patient wait time. Repeated radiographic imaging was reduced by 63% (p < 0.05). Qualitative ratings and open comments supported PV being included in standard SGRT.
Conclusions: The scope of this work was to evaluate a feature under economic considerations. This data demonstrates an increase in quality, safety, accuracy and efficiency of patient setup with PV, and allows us to make an objective, business-focused assessment of the investment in PV.
Keywords: surface-guided radiotherapyreduced imagingtime savingefficiencyreturn on invest
References
- Bertram M, Dhaene G, Tan-Torres Edejer T. Institutionalizing health technology assessment mechanisms: a how to guide. Licence: CC BY-NC-SA 3.0 IGO. Geneva; 2021. https://www.who.int/publications/i/item/9789240020665 (2024 May 24).
- Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs--same or different? Value Health. 2009; 12(4): 402–404.
- Reckers-Droog V, Federici C, Brouwer W, et al. Challenges with coverage with evidence development schemes for medical devices: A systematic review. Health Policy Technol. 2020; 9(2): 146–156.
- Laaksomaa M, Aula A, Sarudis S, et al. Surface-guided radiotherapy systems in locoregional deep inspiration breath hold radiotherapy for breast cancer - a multicenter study on the setup accuracy. Rep Pract Oncol Radiother. 2024; 29(2): 176–186.
- Laaksomaa M, Ahlroth J, Pynnönen K, et al. AlignRT, Catalyst™ and RPM™ in locoregional radiotherapy of breast cancer with DIBH. Is IGRT still needed? Rep Pract Oncol Radiother. 2022; 27(5): 797–808.
- Bolin MC, Falk M, Hedman M, et al. Surface-guided radiotherapy improves rotational accuracy in gynecological cancer patients. Rep Pract Oncol Radiother. 2023; 28(6): 764–771.
- Bert C, Metheany KG, Doppke KP, et al. Clinical experience with a 3D surface patient setup system for alignment of partial-breast irradiation patients. Int J Radiat Oncol Biol Phys. 2006; 64(4): 1265–1274.
- Augier M. The Palgrave encyclopedia of strategic management. Springer Berlin Heidelberg, New York NY 2018.
- Batista V, Gober M, Moura F, et al. Surface guided radiation therapy: An international survey on current clinical practice. Tech Innov Patient Support Radiat Oncol. 2022; 22: 1–8.
- Zhou Li, Bai S, Zhang Y, et al. Imaging Dose, Cancer Risk and Cost Analysis in Image-guided Radiotherapy of Cancers. Sci Rep. 2018; 8(1): 10076.
- Ploquin NP, Dunscombe PB. The cost of radiation therapy. Radiother Oncol. 2008; 86(2): 217–223.
- Sauer TO, Ott OJ, Lahmer G, et al. Prerequisites for the clinical implementation of a markerless SGRT-only workflow for the treatment of breast cancer patients. Strahlenther Onkol. 2023; 199(1): 22–29.
- Steiner E, Healy B, Baldock C. Dose from imaging at the time of treatment should be reduced. Phys Eng Sci Med. 2023; 46(3): 959–962.
- Malicki J, Piotrowski T, Guedea F, et al. Treatment-integrated imaging, radiomics, and personalised radiotherapy: the future is at hand. Rep Pract Oncol Radiother. 2022; 27(4): 734–743.
- Murphy MJ, Balter J, Balter S, et al. The management of imaging dose during image-guided radiotherapy: report of the AAPM Task Group 75. Med Phys. 2007; 34(10): 4041–4063.